7.75 Hrs. of CE You Can't Afford to Miss
You've Got Challenges -- We've got Sessions Offering Vital Guidance
American Pharmacies always strives to bring you continuing education at AEX that can drive a real difference in the success of your pharmacy and your profession. This year's CE lineup addresses some especially critical issues.
DSCA Compliance
The Drug Supply Chain Security Act (DSCSA) was enacted in 2013 to prevent harmful drugs from entering the supply chain, detect them and enable rapid response when such drugs are found. The DSCA includes requirements that pharmacies must follow to protect patients from receiving harmful drugs, such as counterfeit or other illegitimate drugs. These provisions take effect Nov. 23, 2023 and affect all retail pharmacies.
Join Josh Potter of PRS Pharmacy Services at our Friday, June 16, session that will outline your pharmacy's responsibilities under the DSCSA, how to handle adverse events covered by the act and steps you can take to ensure compliance with its provisions.
DIR Fees
CMS issued a final rule that eliminates PBMs' retroactive application of DIR fees in Medicare Part D, requiring that they be reflected in the negotiated price the patient pays starting in January 2024. This creates greater transparency for patients and pharmacies, but does nothing to curb PBMs' ability to assess or increase DIR Fees at the point of sale. The possible impacts on dispensing revenue are both far-reaching and difficult to predict.
Scotty Sykes, CPA, of Sykes and Company will deliver a vital session on Friday, June 16, that covers the changes taking place in 2024, how to reduce DIR assessments against your pharmacy and how to use sound financial and accounting practices to prepare for the uncertainty of a new DIR structure that kicks in at the same time PBMs start recouping fourth-quarter DIR assessments from the previous year.
2023 Advocacy Update
As the most politically engaged and successful independent pharmacy purchasing group, American Pharmacies is deeply engaged in multiple states to drive legislation that protects independents and their patients from PBM abuses. Join VP of Government Affairs Michael Wright on Saturday morning, June 17, for a vital update on important advocacy issues and a how APRx is engaged in multiple states and Washington, D.C., to protect your interests. This session will also feature a panel discussion with our state and federal lobbyists, and recognition of member owners who are vital contributors to our advocacy efforts.
Driving Front-End Success With HME
If you have never heard NOVA founder and CEO Sue Chen speak, you are in for a treat. Sue is a bundle of energy who is passionate about the power of HME products to improve lives while driving an important front-end revenue stream for independent pharmacies. Join her on Thursday, June 15, for an illuminating hour on the rapidly growing HME market, opportunities for pharmacies and how HME can power your pharmacy's front end. You may be worn out at the end of this 60-minute session, but we guarantee that Sue won't be!
Collaborative Practice Agreements
Properly drawn-up and executed CPAs make it possible for you pharmacy to dispense certain drugs after a point of care test, adjust patient medication levels and perform other advanced clinical tasks. Nicolette Mathey of Atrium 24 will cover the essentials of setting up an effective CPA for your pharmacy during her session on Thursday, June 15.
2023 Legal Update
Federal court decisions continue to reshape the legal and legislative landscape for PBM reforms. New opportunities have arisen to curb PBM abuses, but PBMs are shifting legislative strategies to avoid -- or to even try to repeal -- reforms to curb their power and abuses. On Friday, June 16, General Counsel Miguel Rodriguez will talk about how Rutledge v. PCMA, PCMA v. Wehbi and other decisions continue to impact PBM regulation.
You can check out the entire schedule of events here.
|